» Antibiotics Can Kill Healthy Gut Bacteria - Healthline
23/10/21 02

» A model screening pipeline for bile acid converting anti-Clostridioides difficile bacteria reveals unique biotherapeutic potential of Peptacetobacter hiranonis | bioRxiv
23/10/21 02

» Choosing between oral fidaxomicin options – SPS - Specialist Pharmacy Service – The first stop for professional medicines advice
23/10/21 02

» Expert Perspectives on Advances in the Management of Clostrioides difficile: Bezlotoxumab and Unmet Needs - Contagionlive.com
23/10/21 02

» UCI-led study suggests new molecular target for therapeutic interventions aimed at C. difficile infection - EurekAlert
23/10/21 02

» What's the Difference Between ID and Gastro C. difficile Recommendations?
21/10/21 06

» Real-World Comparison of Bezlotoxumab to Standard of Care Therapy for Prevention of Recurrent Clostridioides difficile Infection in Patients at High Risk for Recurrence
21/10/21 06

» Sahil Khanna, MBBS: Emerging Therapies for C Difficile
21/10/21 06

» AcurX Pharmaceuticals’ C. Difficile Drug Candidate Could Fetch $800 Million On A Peer Comparison Basis (NASDAQ: ACXP)
21/10/21 06

» Bottom Line: Study Finds Shoes Major Source of C. Diff - Infection Control
21/10/21 05

» Are Shoes a Vector for C. difficile Infection
21/10/21 05

» Hospitals That Use More Antibiotics May Have More C Difficile Infections
21/10/21 05

» Can FMT Cause or Prevent CRC? Maybe, But There Is More to Consider
21/10/21 05

» Ferring to Present Award-Winning, Real-World Outcomes Analysis for Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent C. Difficile Infection and IBD at ACG 2021 | Business Wire
19/10/21 06

» Biotech lab in Tustin takes unusual donations at $75 a poop – Orange County Register
19/10/21 06

» Antibiotic Use Highly Tied to emC. diff/em in Hospitals - Infectious Disease Special Edition
19/10/21 06

» A guide to Clostridium Difficile | Medipal Knowledge Hub | Medipal
19/10/21 06

» Current Gastroenterology Research and Studies | Borland Groover
19/10/21 06

» Seres Therapeutics Presents Late-Breaking Data from SER-109 Phase 3 ECOSPOR III Study in Recurrent C. Difficile Infection at IDWeek2021 - Yahoo Finance
19/10/21 06

» Icahn School of Medicine at Mount Sinai on Twitter
19/10/21 06

» Fecal microbiota transplants may improve resistance to melanoma immunotherapy | MDedge Dermatology
19/10/21 06

» Researchers Identify Bacteria That Underlie Success of Fecal Microbiota Transplants | Newsroom | Weill Cornell Medicine
19/10/21 06

» Correction to: ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections
19/10/21 06

» An evaluation of toxigenic Clostridioides difficile positivity as a patient outcome metric of antimicrobial stewardship in Saudi Arabia
19/10/21 06

» Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients
19/10/21 06

» Change in Antimicrobial Use during COVID-19 Pandemic in South Carolina Hospitals: A Multicenter Observational Cohort Study
19/10/21 06

» C Difficile Infections Linked to Poor Quality of Life Scores - MD Magazine
19/10/21 05

» Clinical Development Program Shows Promise for Microbiome-Based Therapeutics in Recurrent C. Diff - Pharmacy Times
16/10/21 07

» Cutting edges in Clostridioides difficile infections
16/10/21 07

» Defining the black box: a narrative review of factors associated with adverse outcomes from severe Clostridioides difficile infection
15/10/21 08

» Corticosteroids Do Not Increase the Likelihood of Primary Clostridioides difficile Infection in the Setting of Broad-Spectrum Antibiotic Use
15/10/21 08

» New Study Explores C Difficile Prevalence Outside of Healthcare - MD Magazine
15/10/21 08

» Changes in antibiotic consumption, AMR and Clostridioides difficile infections in a large tertiary-care center following the implementation of institution-specific guidelines for antimicrobial therapy: A nine-year interrupted time series study
15/10/21 08

» Fecal microbiota transplantation and fiber supplementation, better together?
14/10/21 11

» Nanosilver no ‘silver bullet’ in long-term treatment of infections: A popular treatment for microbial infections may lose its effectiveness when used long-term -- ScienceDaily
13/10/21 06

» Medicare Prescription Plans Limit Access to Recommended Drugs for Clostridioides difficile Infection | Clinical Infectious Diseases | Oxford Academic
13/10/21 06

» Regulatory and Technical boundaries for phage therapy and FMT in animals Tickets, Sun, Oct 17, 2021 at 9:00 AM | Eventbrite
13/10/21 06

» New SARS-CoV-2 Assay by CosmosID Eases Disruptions in Supply Chain for Patient Fecal Microbiota Transplantation
13/10/21 06

» Microbes Behind Successful Fecal Microbiota Transplantations May Become Basis for New Treatments | Genomeweb
13/10/21 06

» Tustin biotech company pays $75 for poop; in the end it’s just a job - Press-Enterprise
13/10/21 06

» “This study is another step in the evolution of #FMT. The field is moving away from FMT and toward defined consortium of microbes that can restore a function of the gut microbiome that was lost," says Dr. @grinsa01: https://t.co/vVncX76dwX @CrohnsColiti
13/10/21 06

» BARDA to support Phase 3 trial of treatment for C. difficile bacterial infections
13/10/21 06

» Correction to: An emergent infectious disease: Clostridioides difficile infection hospitalizations, 10-year trend in Sicily
13/10/21 06

» Rehospitalization for CDI Common; Appropriate Patient Follow-up Often Lacking - Infectious Disease Special Edition
11/10/21 11

» SUMMARY - Institutional Perspectives in Infectious Diseases: Management of C. Difficile
11/10/21 11

» Women With Recurrent UTIs Express Fear, Frustration
11/10/21 11

» Not published, but FDX use has basically plateaued after initial 50% or so bump in use in 2018. #CDI #AMR #Cdiff
11/10/21 10

» Medicare Prescription Plans Limit Access to Recommended Drugs for Clostridioides difficile Infection
11/10/21 10

» New SARS-CoV-2 Assay by CosmosID Eases Disruptions in Supply Chain for Patient Fecal Microbiota Transplantation
09/10/21 06

» Vedanta touts positive new data for its C. diff microbiome therapeutic
09/10/21 06